HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The endocannabinoid system and the molecular basis of paralytic ileus in mice.

Abstract
The endocannabinoid system (i.e., the cannabinoid receptors and their endogenous ligands) plays an important role in the physiological control of intestinal motility. However, its participation in intestinal pathological states is still poorly understood. In the present study, we investigated the possible role of the endocannabinoid system in the pathogenesis of paralytic ileus, a pathological state consisting of decreased intestinal motility following peritonitis, surgery, or other noxious situations. Ileus was induced by i.p. administration of acetic acid, and gastrointestinal propulsion was assessed by the charcoal method. Endocannabinoid levels were measured by isotope-dilution gas chromatography-mass spectrometry, whereas cannabinoid CB1 receptors were identified by immunohistochemistry. Acetic acid administration inhibited gastrointestinal transit (ileus), and this effect was accompanied by increased levels of the endocannabinoid anandamide compared with control mice and by overexpression of CB1 receptors in myenteric nerves. Furthermore, acetic acid-induced ileus was alleviated by the CB1 receptor antagonist SR141716A and worsened by VDM11, a selective inhibitor of anandamide cellular uptake (and hence inactivation). From these findings, it can be concluded that the intestinal hypomotility typical of paralytic ileus is due, at least in part, to the enhancement of anandamide levels and CB1 expression during this condition, and that selective, nonpsychotropic CB1 receptor antagonists could represent new drugs to treat this disorder.
AuthorsNicola Mascolo, Angelo A Izzo, Alessia Ligresti, Anna Costagliola, Luisa Pinto, Maria G Cascio, Pasquale Maffia, Aldo Cecio, Francesco Capasso, Vincenzo Di Marzo
JournalFASEB journal : official publication of the Federation of American Societies for Experimental Biology (FASEB J) Vol. 16 Issue 14 Pg. 1973-5 (Dec 2002) ISSN: 1530-6860 [Electronic] United States
PMID12397089 (Publication Type: Journal Article)
Chemical References
  • Arachidonic Acids
  • Cannabinoid Receptor Modulators
  • Endocannabinoids
  • N-(2-methyl-3-hydroxyphenyl)-5,8,11,14-eicosatetraenamide
  • Piperidines
  • Polyunsaturated Alkamides
  • Pyrazoles
  • Receptors, Cannabinoid
  • Receptors, Drug
  • Rimonabant
  • anandamide
Topics
  • Animals
  • Arachidonic Acids (analysis, pharmacology, physiology)
  • Cannabinoid Receptor Modulators
  • Endocannabinoids
  • Enteric Nervous System (chemistry)
  • Gastrointestinal Motility (drug effects)
  • Intestinal Pseudo-Obstruction (etiology, metabolism, physiopathology)
  • Intestine, Small (chemistry, innervation)
  • Mice
  • Models, Biological
  • Neurons (chemistry)
  • Piperidines (pharmacology)
  • Polyunsaturated Alkamides
  • Pyrazoles (pharmacology)
  • Receptors, Cannabinoid
  • Receptors, Drug (analysis, antagonists & inhibitors, metabolism)
  • Rimonabant

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: